好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cognitive Reserve Modulates the Impact of Structural Damage of the Frontal Lobe on Executive Functioning in Multiple Sclerosis
Multiple Sclerosis
P1 - Poster Session 1 (9:00 AM-5:00 PM)
298

To investigate the interaction between cognitive reserve (CR), atrophy of frontal gray matter (GM) areas and microstructural abnormalities of frontal white matter (WM) tracts and their associations with executive functioning (EF) in multiple sclerosis (MS) patients.

Early-life experiences influence the development of frontal brain areas, whose maturation extends into young adulthood. The CR could have a beneficial effect on EF, particularly in MS characterized by EF impairment and frontal lobe damage. 

Ninety-three MS patients and 27 matched healthy controls (HC) underwent brain 3.0 T MRI scans. Frontal gyri GM volumes, lesional volume, fractional anisotropy (FA), mean diffusivity, intracellular volume fraction and orientation dispersion index (ODI) of frontal WM tracts were estimated. Cognitive reserve index (CRI), Wisconsin Card Sorting Test (WCST) and Word List Generation (WLG) of the Rao’s battery were assessed. Structural MRI measures and CRI interaction on cognitive performance were explored with linear models.

Compared to HC, MS patients showed significant GM atrophy and microstructural abnormalities in the majority of regions investigated (p≤0.046) and significant worse performances in categories and total errors of WCST and WLG (p≤0.034). In MS, higher CRI was correlated with better WLG performance, WCST-categories, frontal gyri volumes and diffusivity measures of frontal WM tracts (r from -0.212 to 0.455; p from 0.001 to 0.046). The combination of demographic, clinical, and measures of frontal lobe structural damage significantly explained EF (WLG: R2=0.44; p=0.022; WCST categories: R2=0.33; p=0.010). Higher CRI explained a further portion of variance in WLG (WLG: R2=0.50; p=0.002; ?R2=0.07; p=0.003).

In MS, CRI is associated with higher GM volumes of frontal gyri and higher microstructural integrity of frontal WM tracts. CRI may have a protective role in preserving semantic verbal fluency and cognitive flexibility, possibly moderating the impact of structural damage of the frontal lobe on cognitive performance.

Authors/Disclosures
Paolo Preziosa (Ospedale San Raffaele)
PRESENTER
Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
No disclosure on file
Elisabetta Pagani Elisabetta Pagani has nothing to disclose.
Massimo Filippi, MD, FAAN (Ospedale San Raffaele, Neuroimaging Research Unit) Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Maria A. Rocca (Neuroimaging Research Unit) Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.